Cytel is a multinational statistical software developer and contract research organization, providing clinical trial design, implementation services, and statistical products primarily for the biotech and pharmaceutical development markets. The company specializes in adaptive trials and is known for its scientific rigor and operational excellence.

Cytel

Functional Services

EUGM 2016

CliPLab

Cytel enables decision-makers in the life sciences to unlock the full potential of their products. From navigating uncertainty to proving value, Cytel’s 30 years of global expertise in consulting, data-driven analytics, and industry-leading software helps biotech and pharmaceutical companies transform intelligence into confident decisions. We have an uncompromising commitment to scientific rigor and high standards of operational excellence, which are channeled through our locations in North America, Europe, the United Kingdom, and Asia. Together, we enable our clients to deliver the therapies that propel humanity forward. 

Cytel employs a range of data science tools from biostatistics to machine learning to help executives in the life-sciences to make confident decisions powered by data. We are probably best known for being leaders in the field of adaptive clinical trial design, a subset of trial design that uses interim looks to enhance the patient safety and commercial value of pharmaceutical products. We also have specialists in Bayesian statistics, real world evidence, artificial intelligence, health economics, and a number of other research fields to ensure that academic and scientific findings can have impact on industry quickly and seamlessly.

www.cytel.com

New Mountain Capital

Nordic Capital

Merck Capital Ventures

Cytel today announced that Jovan Willford, a dynamic leader known for transformation, growth, and a customer-centric approach, has been named Chief Executive Officer and member of its Board of Directors. 

“I look forward to working with the deeply talented teams at Cytel to deliver on the outstanding opportunity ahead of us. I am committed to upholding our longstanding legacy of exceptional client service and innovation, while at the same time building on the foundation of scientific rigor and leadership that has made Cytel a valued partner to the largest and most innovative pharmaceutical companies for the last 35 years,” said Willford.

Read more on our website: https://bit.ly/47TQy7m


Interested in learning more about the how to expand your usage of our Solara® software? Download the white paper to gain new insights! https://bit.ly/48YAPVQ

Join us Thursday for a webinar on LiveSLR! There is still time to register for the event and learn new ways to transform market access with Maria Rizzo and Sharada Harricharan. https://bit.ly/3SMIEIp

Are you attending PHUSE US Connect 2024? Meet Cytel's Global Talent Acquisitions team members Jayne Stegman and Rahul Panchal to learn more about Cytel #careers, culture and more. Book a meeting today! https://bit.ly/3vUu2hj #PHUSEUS

Today we recognize #WorldCancerDay. At Cytel, we're proud to partner with our customers who pioneer the way in oncology drug development. 

COM:CYTEL

Cytel

locale

market

industry

website

crunchbase

linkedin

Metrics